Clinical Trial Update: Remaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy

View source ↗

Summary

Remaxol® was studied for drug-induced liver injuries in cancer patients receiving chemotherapy; the clinical trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Drug-induced Liver Injury

Drugs mentioned

• Remaxol

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Cancer, Drug Induced Liver Injury | Status: COMPLETED